DHEA
Showing 1 - 25 of 357
Poor Responders Trial in Bani Suwayf (myo-inositol, Somatropin, Dehydroepiandrosterone)
Not yet recruiting
- Poor Responders
- myo-inositol
- +2 more
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jun 4, 2023
Asthma, Genotype Trial in Indianapolis (Slow Release DHEA)
Recruiting
- Asthma
- Genotype
- Slow Release DHEA
-
Indianapolis, Indiana
- +1 more
Jan 19, 2023
Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause Trial in Stockholm (vaginal estradiol 10 µg, vaginal DHEA 6.5 mg)
Recruiting
- Vulvovaginal Atrophy
- Genitourinary Syndrome of Menopause
- vaginal estradiol 10 μg
- vaginal DHEA 6.5 mg
-
Stockholm, SwedenKarolinska University Hospital
Oct 15, 2022
Pulmonary Arterial Hypertension Trial in Providence (DHEA tablet, Placebo)
Recruiting
- Pulmonary Arterial Hypertension
- DHEA tablet
- Placebo
-
Providence, Rhode IslandRhode Island Hospital Pulmonary Hypertension Center
Mar 25, 2022
Low Bone Density, Osteoporosis Trial in Aurora (Exercise, DHEA)
Enrolling by invitation
- Low Bone Density
- Osteoporosis
- Exercise
- DHEA
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Mar 30, 2022
Dietary Supplements Trial in Kaohsiung (DHEA, DHEA+CoQ10+Tocotrienol)
Recruiting
- Dietary Supplements
- DHEA
- DHEA+CoQ10+Tocotrienol
-
Kaohsiung, TaiwanDepartment of Obstetrics and Gynecology, Kaohsiung Veterans Gene
Jul 21, 2022
Low Bone Mass, Osteoporosis, Postmenopausal Trial in Aurora (DHEA, Placebo, Exercise)
Recruiting
- Low Bone Mass
- Osteoporosis, Postmenopausal
- DHEA
- +2 more
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Feb 14, 2022
COPD, Hypertension, Pulmonary Trial in France (DHEA Treatment)
Completed
- Chronic Obstructive Pulmonary Disease
- Hypertension, Pulmonary
- DHEA Treatment
-
Bordeaux, France
- +3 more
Feb 8, 2022
Chronic Low Back Pain Trial in Durham (Pregnenolone, DHEA, Placebo)
Not yet recruiting
- Chronic Low Back Pain
- Pregnenolone
- +2 more
-
Durham, North CarolinaDurham VA Medical Center, Durham, NC
Jul 11, 2023
Chinese Genitourinary Syndrome of Menopause Treated With Vaginal
Recruiting
- Genitourinary Syndrome of Menopause
- vaginal dehydroepiandrosterone
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Aug 14, 2022
Polycystic Ovary Syndrome, Insulin Resistance, Androgen; Hypersecretion Trial in Dublin 9 (Dehydroepiandrosterone (DHEA),
Recruiting
- Polycystic Ovary Syndrome
- +3 more
- Dehydroepiandrosterone (DHEA)
- 11-ketoandrostenedione (11KA4)
-
Dublin 9, IrelandBeaumont Hospital
Apr 26, 2022
Vulvar Atrophy, Breast Cancer, Genitourinary Syndrome of Menopause Trial in Barcelona (Prasterone (DHEA), Micronized)
Completed
- Vulvar Atrophy
- +2 more
- Prasterone (DHEA), Micronized
-
Barcelona, SpainHospital Clínic de Barcelona
Feb 20, 2022
Polycystic Ovary Syndrome Trial in Birmingham (oral androgen challenge with dehydroepiandrosterone (DHEA))
Recruiting
- Polycystic Ovary Syndrome
- oral androgen challenge with dehydroepiandrosterone (DHEA)
-
Birmingham, West Midlands, United KingdomInstitute of Metabolism and Systems Research
Feb 8, 2022
Polycystic Ovary Syndrome Trial in Cairo (blood test)
Completed
- Polycystic Ovary Syndrome
- blood test
-
Cairo, EgyptKafrelsheikh University
Jul 9, 2021
PTSD Trial in Durham (DHEA)
Terminated
- Posttraumatic Stress Disorder
- DHEA
-
Durham, North CarolinaDurham VA Medical Center, Durham, NC
Apr 6, 2021
Oxidative Stress in Polycystic Ovary Syndrome With Periodontal
Completed
- Polycystic Ovary Syndrome
- Dental Caries
- polycystic ovary syndrome
-
Rize, TurkeyRecep Tayyip Erdogan University
Sep 1, 2021
Poor Responders, Dehydroepiandrosterone Trial in Kaohsiung City, Kaohsiung (dehydroepiandrosterone (DHEA))
Completed
- Poor Responders
- Dehydroepiandrosterone
- dehydroepiandrosterone (DHEA)
-
Kaohsiung City, Taiwan
- +1 more
Feb 17, 2021
Vaginal Atrophy in Breast Cancer Patients Trial (Placebo, Prasterone (DHEA))
Withdrawn
- Vaginal Atrophy in Breast Cancer Patients
- Placebo
- Prasterone (DHEA)
- (no location specified)
Jul 29, 2020
Hypoactive Sexual Desire Disorder (HSDD) Trial in United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal
Withdrawn
- Hypoactive Sexual Desire Disorder (HSDD)
- Placebo Vaginal Insert
- Prasterone 6.5 mg (0.50%) Vaginal Insert
-
Huntsville, Alabama
- +9 more
Jul 29, 2020
Primary Ovarian Insufficiency, Female Infertility Due to Diminished Ovarian Reserve Trial in New York, Rochester (Testosterone
Recruiting
- Primary Ovarian Insufficiency
- Female Infertility Due to Diminished Ovarian Reserve
- Testosterone cream (0.5mg per gram)
- +2 more
-
New York, New York
- +1 more
Nov 9, 2020
Contraceptive Usage, Coagulation Trial in Portland (DHEA Oral Capsule, Placebo Oral Capsule)
Completed
- Contraceptive Usage
- Coagulation
- DHEA Oral Capsule
- Placebo Oral Capsule
-
Portland, OregonOregon Health & Science University
Jan 22, 2020
Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris
Recruiting
- Acne Vulgaris
- Hormone
- Isotretinoin
-
Istanbul, TurkeyMarmara University School of Medicine,Department of Dermatology.
Jun 11, 2023
Infertility Trial (DHEA)
Completed
- Infertility
- DHEA
- (no location specified)
Sep 17, 2019
Synovial Sarcoma, Sarcoma, Synovial Trial in Saint Louis (DHEA, FACT-67 validated survey)
Terminated
- Synovial Sarcoma
- Sarcoma, Synovial
- DHEA
- FACT-67 validated survey
-
Saint Louis, MissouriWashington University School of Medicine
Sep 4, 2019
Hypoactive Sexual Desire Disorder Trial in Canada, United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal
Completed
- Hypoactive Sexual Desire Disorder
- Placebo Vaginal Insert
- Prasterone 6.5 mg (0.50%) Vaginal Insert
-
Huntsville, Alabama
- +68 more
Apr 7, 2021